← Pharmacist Notes

DRUG · COUNSELLING NOTES

Lisocabtagene Maraleucel

BREYANZI

Updated

New prescription

indication: _____. one-time hospital infusion; no driving 8 wks; warned on allergies; serious/common AEs: cytokine release syndrome, confusion, infections; non-pharm: infection precautions.

Refill prescription

refilled, adherence discussed, no SEs were reported

Dose change

Dose change discussed. new dose reviewed; one-time hospital infusion; no driving 8 wks; warned on allergies; serious/common AEs: cytokine release syndrome, confusion, infections; non-pharm: infection precautions.

View Lisocabtagene Maraleucel in the Drug Database

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.